SmartPharma Group, UAB Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 446,037 |
| 437,291 |
| 26,112 |
| 22,195 |
| 21,760 |
| 17.25 |
| 4.98 |
| 65,736 |
| 222,515 |
| 29,388 |
| 258,588 |
| 2024 |
|---|
| 858,736 |
| 727,742 |
| 321,651 |
| 273,400 |
| 231,695 |
| 42.52 |
| 31.84 |
| 339,136 |
| 82,909 |
| 273,657 |
| 148,388 |
| 2025 |
|---|
| 680,059 |
| 340,030 |
| 167,855 |
| 140,962 |
| 70,481 |
| 30.99 |
| 20.73 |
| 480,098 |
| 205,396 |
| 484,390 |
| 199,997 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 680,059 |
| 340,030 |
| 167,855 |
| 140,962 |
| 70,481 |
| 30.99 |
| 20.73 |
| 480,098 |
| 205,396 |
| 484,390 |
| 199,997 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
680,059 €-21 % *
Sales per employee (€)
340,030 €-53 % *
Profit before tax (€)
167,855 €-48 % *
Net Profit (€)
140,962 €-48 % *
Profit per employee (€)
70,481 €-70 % *
Total profitability (%)
30.99 %-27.12 % *
Net profitability (%)
20.73 %-34.89 % *
Equity (€)
480,098 €42 % *
Amounts Payable And Liabilities (€)
205,396 €148 % *
Non-current Assets (€)
484,390 €77 % *
CurrentAssets (€)
199,997 €35 % *
